Phase 3 Chronic Rhinosinusitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with Cystic Fibrosis and are currently taking a highly effective modulator therapy (a specific type of Cystic Fibrosis medication — confirm with trial site if unsure)
- You have a history of chronic sinusitis (long-term inflammation of the sinuses and nasal passages)
- You are currently using nasal rinses/washes, with or without added medications such as steroids or antibiotics
Who may not be able to join:
- You are under 18 years of age
- You have Cystic Fibrosis but are NOT currently taking a highly effective modulator therapy
- You are currently pregnant
- You are not currently using nasal rinses/washes as part of your care
- You have a history of tumors in your sinuses, nasal passages, or the area at the back of your nose and throat
- You currently have an active sinus infection or an active lung infection
- You were admitted to hospital for a serious lung flare-up within the last 3 months
- You have taken antibiotic tablets or capsules for a nose, throat, or lung infection within the last month
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elisa Illing, MD, Indiana University
Phone: 317-944-6467
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Lund Kennedy Score; Change in Pulmonary Function Testing; Change in Body Mass Index (BMI); Change in Health Care Utilization; Change in Sinonasal Outcome Test 22 Questionnaire (SNOT-22) Score; Change in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Score; Change in Patient Health Questionnaire-9 (PHQ-9) Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.